The largest database of trusted experimental protocols

Mmwp workstation

Manufactured by Siemens
Sourced in Germany

The MMWP workstation is a laboratory equipment product offered by Siemens. It serves as a platform for various applications and experiments. The core function of the MMWP workstation is to provide a controlled and customizable environment for research and analysis tasks.

Automatically generated - may contain errors

11 protocols using mmwp workstation

1

Ga-68 PSMA-617 PET/CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intravenous injection of the tracer was performed with an injection activity of 111.1– 148.0 MBq. After 45–60 minutes, 68Ga-PSMA-617 PET/CT imaging (Siemens Medical Solutions, Erlangen, Germany) was performed. All PET acquisition was carried out in three-dimensional mode, 2 min per bed, 5–6 bed positions per patient. PET reconstruction used low-dose CT (120 kV, 35 mA, 512 × 512 matrix, 3-mm layer, 70 cm field of view) for attenuation correction and an ordered-subset expectation maximization iterative algorithm with 2 iterations and 8 subsets, with a 5-mm full width at half maximum postreconstruction Gaussian filter. A Siemens MMWP workstation was used for post-processing. Regions of interests (ROIs) were manually drawn including the main organs (heart, lung, pancreas, liver, spleen, stomach, muscle and salivary glands) and around the target tumor lesions (up to six lesions per patient) on PET slices by referring CT images. The post-processing workstation automatically calculated the volume of interest and SUVs.
+ Open protocol
+ Expand
2

Ga-DOTATATE PET/CT for Therapy Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
68Ga-DOTATATE PET/CT were performed at baseline and 2–3 months post-therapy for response evaluation. No specific preparation was requested before intravenous injection of 68Ga-DOTATATE at a dosage of approximately 1.85 MBq (0.05 mCi) per kilogram body weight. PET/CT scan was performed at 40 min after tracer administration. After a low-dose CT scan, whole-body PET was performed with 2 min/bed position (5–6 bed positions depending on the height of the patient) from the pelvic bottom to the skull base. The emission data were corrected for randoms, dead time, scattering and attenuation. A Siemens MMWP workstation was used for post-processing.
All images were measured by the same physician who was masked to the clinical data. The regions of interest (ROI) of tumor lesions were drawn manually and the software automatically obtained the radioactivity concentration and standard uptake of value (SUV) in the ROI. The SUVmax of lesions with longest diameter ≥2.0 cm was calculated and no more than 5 lesions (no more than 2 lesions in an organ as well) in one patient were measured. Molecular tumor response was evaluated referring to EORTC criteria.
+ Open protocol
+ Expand
3

Multimodal Imaging of Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 68Ga-PSMA-617 PET/CT images were reviewed by consensus between three experienced nuclear medicine physicians by using Siemens MMWP workstation. PCa lesions were distinguished from the surrounding normal prostate tissues by visual analysis. To calculate the 68Ga-PSMA-617 uptake of the primary PCa lesion, circular regions of interest (ROIs) were drawn around areas with focally increased uptake in transaxial slices by using e.soft software (Siemens) at a 30% threshold, and SUVmax was calculated automatically. Scans were considered positive when the focal uptake of 68Ga-PSMA-617 was superior to the background activity. Semiquantitative measures comprised SUVmax and SUVratio (explained below under “Statistical analysis”).
The positive criterion for mpMRI is an abnormal focal signal increase or decrease. The readers were instructed to decide on the basis of their overall impression by using the 5-point Prostate Imaging Reporting and Data System (PI-RADS) score19 (link): 1, PCa highly unlikely; 2, PCa unlikely; 3, equivocal PCa; 4, PCa likely; and 5, PCa highly likely. At the patient level, data were dichotomized (score of 1–2, PCa negative; score of 3–5, PCa positive) using the highest score per patient.
+ Open protocol
+ Expand
4

Quantitative Analysis of Lesion Biodistribution

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Siemens MMWP workstation was used for post-processing. Visual analysis was used to determine the general biodistribution and the temporal and inter-subject stability. Regions of interest (ROIs) were drawn manually on the site of lesions using 3D ellipsoid isocontour on each image with the assistance of the corresponding CT images by two experienced nuclear medical physicians. They were different from the physicians who previously recruited the patients and interpreted the images through consensus reading and blinded to the history, other examinations, and pathologic diagnosis of the patients. Per-lesion analysis was performed for the diagnosis of breast lesions, lung, liver and bone metastases. Per-region analysis was adopted for the diagnosis of lymph node metastases because of the difficulty to correlate the lymph nodes lesion by lesion between the images and pathologic diagnosis. For semi-quantitative analysis, the results were expressed as mean and maximum standardized uptake value (SUVmean and SUVmax).
+ Open protocol
+ Expand
5

Quantitative PET/CT Imaging of Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PET/CT images were manipulated on a Siemens MMWP workstation. PET images were jointly analyzed by two experienced nuclear medicine physicians. For 68Ga-NOTA-RM26 PET/CT imaging, PET positivity was defined as focal tracer uptake of the primary tumor or lymph nodes over the local background, in correlation with CT. The tumors with uptakes similar to or lower than breast tissue were defined as PET negative. The maximum and mean standardized uptake values (SUVmax and SUVmean, respectively) in the volumes of interest were acquired through the software. The tumor-to-background (T/B) ratios were calculated for further analysis. The peripheral breast tissue was considered as background for calculation.
+ Open protocol
+ Expand
6

Standardized 18F-FDG PET/CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Siemens Biography MCT-64 PET/CT scanning equipment was used for the examination. 18F-FDG developer automatically synthesized by Sumitomo cyclotron and a chemical synthesis module, radiochemical purity > 99%. Patients fasting for more than 6 h before the examination, with blood glucose < 11.1mmol/L after injection of 18F-FDG at 4.0 MBq/kg body mass, the patients were instructed to lie still for 1 h. PET/CT imaging was performed after urination, with the acquisition range from the cranial vault to the mid-femur, and 6 to 7 beds were acquired. Prior CT scan: tube voltage 140 kV, effective current 42 mAs, pitch 0.8, spherical tube single-turn rotation time 0.5 s, layer thickness 8 mm. PET scans were acquired in 3D, 1.5 min/bed, with delayed imaging, if necessary. Images were reconstructed using the ordered subsets expectation maximization (OSEM) iterative algorithm, and image fusion and post-processing were performed on a Siemens MMWP workstation.
+ Open protocol
+ Expand
7

Standardized 18F-FDG PET/CT and 18F-Alfatide II PET Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The standard protocol for an 18F-FDG PET/CT scan was adopted. Patients were asked to fast for 4-6 h immediately before the scan. An 18F-FDG dose of 10 ± 1.5 mCi (370 ± 55.5 MBq) was intravenously administered. At 1 h after injection, the patients were scanned on a Siemens TruePoint HD scanner. 18F-Alfatide II PET was performed within 1 to 3 days after the 18F-FDG PET. No patient preparation was required for the 18F-Alfatide II PET scan. The injection dose of 18F-Alfatide II was 8 ± 1.0 mCi (296 ± 37 MBq). At 1 h after injection, the patients were scanned on the same Siemens TruePoint HD scanner. For both radiopharmaceuticals, whole-body (vertex to thigh) PET/CT images were obtained in 3D mode (2 min per bed position). Low-dose helical CT transmission scan (pitch 0.8, 50 mAs, 120 kV (peak)) was performed first for each of the 2 scans. Raw CT data were reconstructed into 3.75 mm-thick sections of transverse images, and reformatted sagittal and coronal CT images were generated. CT-based attenuation-corrected PET images were reconstructed with a standard iterative algorithm (OSEM, 3 iterative steps, 21 subsets) and reviewed using the same Siemens MMWP workstation.
+ Open protocol
+ Expand
8

Gallium-68 BBN-RGD PET/CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The macrocyclic chelator, 1,4,7-triaza cyclononane-N, N', N”-triacetic acid (NOTA) conjugated BBN-RGD was synthesized according to a method described in our previous publication 17 (link). 68Ga-BBN-RGD was prepared following the procedure reported previously 24 (link). The radiochemical purity was greater than 95%.
No specific subject preparation, such as fasting, was requested on the day of 68Ga-BBN-RGD PET/CT. Each patient was intravenously injected with 68Ga-BBN-RGD in a dosage of approximately 1.85 MBq (0.05 mCi) per kilogram of body weight, ranging from 75.9 to 148.0 (114.7 ± 17.1) MBq. PET/CT was performed at 25~35 min after tracer administration by using Biograph 64 Truepoint TrueV system (Siemens Medical Solutions, Knoxville, TN, USA). After a low-dose CT scan (120 kV, 35 mA, 3 mm layer, 512 × 512 matrix, 70 cm FOV), whole body PET acquisition was performed with 2 min per bed position (five to six bed positions depending on the height of the patient). The emission data were corrected for randoms, dead time, scattering, and attenuation. The conventional reconstruction algorithm was used and the images were zoomed with a factor of 1.2. The images were transferred to a MMWP workstation (Siemens) for analysis.
+ Open protocol
+ Expand
9

PET/CT Imaging of Estrogen Receptor Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
18F-FES was prepared as described previously.13 (link) PET/CT imaging was performed from the skull base to the upper thigh using a Discovery PET/CT 690 or 710 scanner (GE Healthcare), 80–100 min after an intravenous injection of 111–222 MBq (3–6 mCi) of 18F-FES.14 (link) PET/CT images were reconstructed using a manufacturer-provided iterative algorithm with four iterations and 18 subsets.18F-FDG (18F-fluorodeoxyglucose) PET/CT images were obtained from the skull base to the upper thigh using one of several different PET/CT scanners (Biograph Sensation 16 or Biograph TruePoint 40, Siemens Healthineers; or Discovery PET/CT 690, 690 Elite, or 710, GE Healthcare), 50 min–70 min after an intravenous injection of 5.2 MBq/kg–7.4 MBq/kg (0.14 mCi/kg–0.2 mCi/kg) of 18F-FDG as described previously.15 (link) The reconstructed images were displayed on coronal, horizontal, sagittal, and three-dimensional (3D) volumetric films and reviewed independently by two nuclear medicine physicians. SUV was calculated automatically (SUV = average radioactivity per gram of tissue/radioactivity of the injected nuclides/mass). Regions of interest (ROIs) were drawn automatically by the Siemens MMWP workstation. To reduce the partial volume effect, the SUVmax corresponded to all pixels in an ROI, and the 18F-FES SUVmax of the corresponding lesions was measured.
+ Open protocol
+ Expand
10

Quantitative Perfusion Analysis of Cerebral Lesions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Imaging images were observed and analyzed by 2 experienced imaging physicians, and a unified opinion was reached on the abnormal perfusion area. Siemens MMWP workstation was used for calculation. The middle cerebral artery was the input artery and the internal jugular vein was the output vein. The location and size of possible lesions were determined manually, and vascular calcification and old infarcted tissue were avoided as far as possible. Quantitative function graphs and perfusion parameters such as cerebral blood flow (CBF), cerebral blood volume (CBV), mean peak time (MTT) and peak time (TTP) were automatically generated by computer. Then, the mirror image method was used to place the region of interest on the opposite side, and the circular region of interest on the corresponding part of the opposite side was placed, and the average value was taken. The relative parameter values of lesions (rCBF, rCBV, rMTT, rTTP) were obtained by comparing the parameters of lesions with those of normal lesions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!